/PRNewswire/ Total Brain, a mental health monitoring and support platform, today announced that the company will license its International Study to Predict.
/PRNewswire/ Total Brain, a mental health monitoring and support platform, today announced that the company will license its International Study to Predict.
A pair of West Coast health firms have announced a partnership to launch a decentralized clinical study in precision psychiatry.The collaboration between Alto Neuroscience Inc. and Cerebral Inc. will provide Cerebral patients who have not responded well to therapy for major depressive disorder with access to Alto’s approach, which aims to match each patient with the appropriate drug to
Before the pandemic forced remote work, school, and research to the forefront, decentralized clinical trials were probably on the horizon. Now, they’re here in earnest. This week, precision psychiatry startup Alto Neuroscience and Cerebral, an online mental health provider, announced that they’ve joined forces for a decentralized Phase 2 clinical trial for Alto Neuroscience’s depression […]